Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $52.18 Analyst target: $71.50 Upside: 37.03%
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases. The company is headquartered in Deer Park, Illinois.
See the full interactive analysis & chart →Informational only — not investment advice.